Evidence map›Paper›PMID 32779305›Full record

ArticlePhytotherapy research : PTR2020

High affinity interaction of Solanum tuberosum and Brassica juncea residue smoke water compounds with proteins involved in coronavirus infection.

Gaurav S Dave, Kalpna D Rakholiya, Mital J Kaneria, Bhemji P Galvadiya, Sudhanshu R Vyas, Vaktabhai H Kanbi, Manubhai P Patel

Open access · bronzeAbstract read
In one paragraph

Article in Phytotherapy research : PTR, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed, 1 pooled it
0.3field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 1 synthesis or guideline pooled it, 19 citations in OpenAlex.

  1. Pooled it
  2. Anticancer Efficacy and Metabolomic Profiling ofAnti-cancer agents in medicinal chemistry · 2026
    Article
  3. Article
  4. Review
  5. Phytochemical characterization ofFrontiers in chemistry · 2023
    Article
  6. Bioactive compounds as potential angiotensin-converting enzyme II inhibitors against COVID-19: a scoping review.Inflammation research : official journal of the European Histamine Research Society ... [et al.] · 2022
    Article
  7. Phytocompounds and COVID-19: Two years of knowledge.Phytotherapy research : PTR · 2022
    Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Gaurav S DaveDepartment of Biochemistry, College of Basic Science and Humanities, Sardarkrushinagar Dantiwada Agricultural University, Sardarkrushinagar, India.ORCID https://orcid.org/0000-0001-5317-9217
Kalpna D RakholiyaDepartment of Biosciences (UGC-CAS), Saurashtra University, Rajkot, 360005, India.
Mital J KaneriaDepartment of Biosciences (UGC-CAS), Saurashtra University, Rajkot, 360005, India.ORCID https://orcid.org/0000-0003-4498-6003
Bhemji P GalvadiyaDepartment of Genetics and Plant Breeding, C. P. College of Agriculture, Sardarkrushinagar Dantiwada Agricultural University, Sardarkrushinagar, India.
Sudhanshu R VyasAspee College of Home Science and Nutrition, Sardarkrushinagar Dantiwada Agricultural University, Sardarkrushinagar, India.
Vaktabhai H KanbiDepartment of Biochemistry, College of Basic Science and Humanities, Sardarkrushinagar Dantiwada Agricultural University, Sardarkrushinagar, India.
Manubhai P PatelPulses Research Station, Sardarkrushinagar Dantiwada Agricultural University, Sardarkrushinagar, India.
Sardarkrushinagar Dantiwada Agricultural University · INSaurashtra University · IN

Funding

CBSH, SDAU
6 · The paper itself

Abstract

The world is in an immediate need of treatment for coronavirus disease (COVID-19). Chronic exposure of hydroxychloroquine in the treatment of COVID-19 may have multiple adverse effects on human physiology, such as cardiac arrhythmias. Natural compounds need to be evaluated as treatment and preventive agents in coronavirus infection. A total of 30 compounds of Solanum tuberosum and Brassica juncea residue smoke water were selected for the virtual screening against SARS-CoV-1, SARS-CoV-2 and cellular proteins involved in the mechanism of infection. Docking analysis identified lead molecules with favorable binding energy, number of poses and hydrogen bond interactions, which indicates the effective modulation of ACE2 and TMPRSS2 receptors. Results indicated (a) curcumenol, (b) N-desmethylselegiline, (c) phentermine and (d) sphingolipid derivatives as a selective and potent candidates in comparison to hydroxychloroquine for COVID-19 treatment. Our in silico findings, therefore, warrant further in vitro validations of the selected compounds for the discovery of novel preventive and therapeutic drug against SARS-CoV-2 infection.

Indexed as

Mustard PlantSmokeSolanum tuberosumAngiotensin-Converting Enzyme 2Antiviral AgentsComputer SimulationCOVID-19 Drug TreatmentHydroxychloroquineMolecular Docking SimulationPhytochemicalsSARS-CoV-2Serine EndopeptidasesSevere acute respiratory syndrome-related coronavirusWaterACE2 protein, humanAngiotensin-Converting Enzyme 2Antiviral AgentsHydroxychloroquinePhytochemicalsSerine EndopeptidasesSmokeTMPRSS2 protein, humanWaterCOVID-19molecular dockingphytoconstituentssmoke water

Identifiers

PMID32779305
PMCPMC7436924
OpenAlexW3048306246

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.